At Least 50 African Children Paralyzed After Receiving Bill Gates-Backed Meningitis Vaccine
naturalnews.com“Bill and Melinda Gates have been on a crusade for at least the past decade to vaccinate every single child on the planet. And one of their primary geographical targets has been the continent of Africa, where poor sanitations and lack of clean water have created conditions in which diseases like meningitis and malaria run rampant. But rather than try to meet these basic needs, the multi-billionaires and their many allies have instead thrust vaccines on indigenous populations as the solution, which has in turn sparked a wave of paralysis among Africa’s younger populations.”
267 000 Doses Applied During Vaccination Week Hidalgo : http://newish.info/19093-267-000-doses-applied-during-vaccination-week-hidalgo
Vaccine Trial Reveals Weak Spots in HIV's Armor
scientificamerican.com…A paper published in Nature today1 sheds light on how a vaccine can turn the immune system against the invading virus and so offer protection from infection. The results are also being presented at the AIDS Vaccine 2012 conference in Boston, Massachusetts, this week.
The findings help to explain the results from a clinical trial of an AIDS vaccine that have puzzled researchers since they were published three years ago2. The trial, called RV144, was the first to score a success and see a reduction in HIV infections. But the vaccine’s relatively low response rate of 31% left researchers scratching their heads.
A clue emerged last year with the revelation that those who responded to the vaccine and fended off HIV tended to produce antibodies against a specific part of the virus’s protein shell called the V1/V2 loop3. The study published today goes a stage further, showing that the people who were vaccinated yet still contracted HIV had been infected by viruses that had mutations in the the V2 portion.
“This is a really good paper,” says Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland. “It adds to the growing body of information indicating that an immune response against components of the V1/V2 loop is important in vaccine-induced protection against infection.”
CDC Study Finds No Link Between Vaccines and Autism
At least 10% of parents of young children skip or delay routine vaccinations, often out of concern that kids are getting “too many shots, too soon.”
A new study finds that children who receive the full schedule of vaccinations have no increased risk of autism.
“This is a very important and reassuring study,” says Geraldine Dawson, chief science officer at Autism Speaks, who wasn’t involved in the new paper. “This study shows definitively that there is no connection between the number of vaccines that children receive in childhood, or the number of vaccines that children receive in one day, and autism.”
On the Malaria Vaccine
A recent WHO report indicates that nearly a third of all countries affected by malaria are on course to eliminate the disease over the next 10 years. Though malaria can lead to complications or even death, it is a preventable and curable illness caused by a parasite that is passed from one human to another through the bite of infected Anopheles mosquitoes. Infected individuals frequently experience high fevers, flu-like symptoms, and anemia; and in 2008 malaria caused between 190 and 311 million clinical episodes and between 708,000 and 1,003,000 deaths. Anti-malarial medications, insecticidal nets, and other control and prevention measures have saved an estimated 1.1 million lives in Africa over the past 10 years, but the availability of an effective vaccine is vital to halt its spread.
In the 109 countries and territories where the risk of malaria transmission is the greatest, newly developed malaria vaccines could save lives. Reports indicate that there were 225 million cases of malaria and an estimated 781,000 deaths in 2009, but these figures have steadily declined in recent years. Though preventative measures have helped to reduce infection rates, experts note that the development and use of a malaria vaccine could reduce them further. During a major clinical trial, a recently produced experimental vaccine known as RTS,S halved the risk of children in Africa contracting malaria. Currently children under five years of age account for the majority of the 800,000 people who die each year as a result of malaria. According to the developers of the vaccine, the adverse effects observed during the vaccine trial are comparable to those seen in children receiving other vaccines.
The RTS,S vaccine triggers an immune response which targets the Plasmodium falciparum parasite that causes malaria. This immune response prevents the parasite from maturing and multiplying in the liver of the vaccinated individual. Unlike other previously developed malaria vaccines, this new vaccine has been created to target different forms of the disease and to trigger a range of antibody responses. Though researchers have been working for 40 years to develop an effective malaria vaccine, to date the outcomes have not been entirely successful. Additional research and testing of the RTS,S vaccine is needed, but according to Dr. Mary Hamel of the Centers for Disease Control and Prevention, “these findings show we are on track in the development of a vaccine.”
With further testing and refinement, this vaccine has the potential to save millions of lives each year and eradicate a disease that affects 3.3 million people – half the world’s population. An effective malaria vaccine could reduce malaria-related deaths, 89 percent of which occur in Africa, and could improve the lives of individuals in regions impacted by the diseases.
Discuss this and other public health topics in the iCons in Medicine forums
